Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 2, 2003, Pages 283-289

  Wang, L Z ^a   Ho, P C ^a   Lee, H S ^a   Vaddi, H K ^a   Chan, Y W ^b   Yung, Chan Sui ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Paclitaxel; Rat plasma; Reversed phase HPLC

Indexed keywords

2' METHYLPACLITAXEL; ACETONITRILE; AMMONIUM ACETATE; BUFFER; METHANOL; PACLITAXEL; PACLITAXEL DERIVATIVE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VERAPAMIL;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG EXPOSURE; EFFLUENT; LIGHT ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STANDARD;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PACLITAXEL; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0037467082     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00611-8     Document Type: Article

References (18)

1. Huizing M.T., Sewberath Misser V.H., Peters R.C., et al. Cancer Invest. 13:1995;381-404.
2. Donehower R.C., Rowinsky E.K. Cancer Treat. Rev. 19:1993;63-78. Suppl.
3. Koeller J.M., Burris H.A., Dorr R.T., et al. Ann. Pharmacother. 28:1994;S5-S36. Suppl. S MAY.
4. Liebmann J.E., Cook J.A., Lipschultz C., et al. Br. J. Cancer. 68:1993;1104-1109.
5. Willey T.A., Bekos E.J., Gaver R.C., Duncan G.F., et al. J. Chromatogr. B. 621:1993;231-238.
6. Sparreboom A., van Tellingen O., Nooijen W.J., Beijnen H.H. J. Chromatogr. B. 664:1995;383-391.
7. Song D., Au J.L. J. Chromatogr. B. 663:1995;337-344.
8. Sparreboom A., de Bruijn P., Nooter K., Loos W.J., Stoter G., Verweij J. J Chromatogr. B. 705:1998;159-164.
9. J.G. Supko, R.V. Nair, M.V. Seiden, H. Lu, J. Pharm. Biomed. Anal. (1999) 1025-36.
10. Leu J.G., Chen B.X., Schiff P.B., Erlanger B.F. Cancer Res. 53:1993;1388-1391.
11. Grothaus P.G., Raybould T.J.G., Bignami G.S., Lazo G.B., Byrnes J.B. J. Immunol. Methods. 158:1993;5-15.
12. Bitsch F., Ma W., McDonald F., Nieder M., Shackleton C.J.L. J. Chromatogr. 615:1993;273-280.
13. Poon G.K., Wade J., Bloomer J., Clarke S.E., Maltas J. Rapid Commun. Mass. SP. 10:1996;1165-1168.
14. Hempel G., Lehmkuhl D., Krumpelmann S., Blaschke G., Boos J. J. Chromatogr. 745:1996;173-179.
15. Hubert P., Chiap P., Moors M., Bourguignon B., Massart D.L. J. Chromatogr. A. 665:1994;87.
16. Guidance for industry-Bioanalytical Method Validation, Internet at http://www.fda.gov/cder/guidance/index.htm.
17. The Merck Index, Eleventh edition, 1989.
18. Lee S.H., Yoo S.D., Lee K.H. J. Chromatogr. B. 724:1999;357-363.